University of Pennsylvania, U.S.
New findings from University of Pennsylvania, U.S., described
Published in Telemedicine Law Weekly, January 13th, 2007
This trend article about University of Pennsylvania, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Investigators publish new data in the report "Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006). Activation of the Raf-MEK-ERK signal transduction pathway in endothelial cells is required for angiogenesis. Raf is the kinase most efficiently inhibited by the multikinase inhibitor sorafenib, which has shown activity against certain human cancers in clinical trials," scientists writing in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
More Articles from Telemedicine Law Weekly
- Abdominal Aortic Aneurysm
Study results from Hamamatsu University, Division of Vascular Surgery update understanding of abdominal aortic aneurysm - Alcohol Use
Brain can recover from alcoholic damage but patients should stop drinking as soon as possible - Alzheimer Disease
Findings in alzheimer disease reported from Kyushu University - Analytical Chemistry
New analytical chemistry research from Purdue University described - Analytical Chemistry
Research from University of Birmingham in the area of analytical chemistry published - Analytical Chemistry
Research from University of Hohenheim, Institute of Food Chemistry yields new findings on analytical chemistry - More from this issue of Telemedicine Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
